| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 151.921 | 81 |
| GSM780708 | Untreated after 4 days (C2_1) | 129.126 | 79 |
| GSM780709 | Untreated after 4 days (C3_1) | 132.602 | 79 |
| GSM780719 | Untreated after 4 days (C1_2) | 172.878 | 82 |
| GSM780720 | Untreated after 4 days (C2_2) | 115.977 | 77 |
| GSM780721 | Untreated after 4 days (C3_2) | 144.593 | 80 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 102.702 | 76 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 155.026 | 81 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 125.319 | 78 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 124.107 | 78 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 136.69 | 79 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 123.827 | 78 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 165.772 | 82 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 137.951 | 79 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 136.79 | 79 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 141.363 | 80 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 144.117 | 80 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 152.145 | 81 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 159.507 | 81 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 145.36 | 80 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 100.407 | 75 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 136.403 | 79 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 119.711 | 78 |